BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
3.860
-0.030 (-0.77%)
At close: Dec 30, 2025
37.86%
Market Cap331.44M
Revenue (ttm)295.81M
Net Income (ttm)-2.82M
Shares Out85.86M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,247
Average Volume38,395
Open3.890
Previous Close3.890
Day's Range3.810 - 3.950
52-Week Range2.795 - 4.700
Beta0.18
RSI41.68
Earnings DateFeb 6, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.